Thompson Investment Management Lowers stake in Zimmer Biomet Holdings Inc (ZBH)

Zimmer Biomet Holdings Inc (ZBH) : Thompson Investment Management reduced its stake in Zimmer Biomet Holdings Inc by 7.73% during the most recent quarter end. The investment management company now holds a total of 31,685 shares of Zimmer Biomet Holdings Inc which is valued at $4,132,675 after selling 2,655 shares in Zimmer Biomet Holdings Inc , the firm said in a disclosure report filed with the SEC on Aug 1, 2016.Zimmer Biomet Holdings Inc makes up approximately 0.81% of Thompson Investment Management’s portfolio.

Other Hedge Funds, Including , Evercore Wealth Management boosted its stake in ZBH in the latest quarter, The investment management firm added 68 additional shares and now holds a total of 4,612 shares of Zimmer Biomet Holdings Inc which is valued at $601,543. Zimmer Biomet Holdings Inc makes up approx 0.03% of Evercore Wealth Management’s portfolio.American Century Companies Inc reduced its stake in ZBH by selling 393,994 shares or 12.08% in the most recent quarter. The Hedge Fund company now holds 2,866,519 shares of ZBH which is valued at $351,664,551. Zimmer Biomet Holdings Inc makes up approx 0.39% of American Century Companies Inc’s portfolio.Joel Isaacson boosted its stake in ZBH in the latest quarter, The investment management firm added 200 additional shares and now holds a total of 373 shares of Zimmer Biomet Holdings Inc which is valued at $46,431. Zimmer Biomet Holdings Inc makes up approx 0.01% of Joel Isaacson’s portfolio.

Zimmer Biomet Holdings Inc opened for trading at $130.62 and hit $131.08 on the upside on Thursday, eventually ending the session at $130.91, with a gain of 0.37% or 0.48 points. The heightened volatility saw the trading volume jump to 9,69,225 shares. Company has a market cap of $26,082 M.

On the company’s financial health, Zimmer Biomet Holdings Inc reported $2.02 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $1.97. The company had revenue of $1934.00 million for the quarter, compared to analysts expectations of $1898.18 million. The company’s revenue was up 65.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.58 EPS.

Many Wall Street Analysts have commented on Zimmer Biomet Holdings Inc. Company shares were Reiterated by Needham on Jul 29, 2016 to “Buy”, Firm has raised the Price Target to $ 150 from a previous price target of $143 .Company shares were Reiterated by Needham on Jul 18, 2016 to “Buy”, Firm has raised the Price Target to $ 143 from a previous price target of $134 .Zimmer Biomet Holdings Inc was Initiated by Guggenheim to “Neutral” on Jun 9, 2016.

Zimmer Biomet Holdings Inc. formerly Zimmer Holdings Inc. is a musculoskeletal healthcare company. The Company designs manufactures and markets orthopedic reconstructive products; sports medicine biologics extremities and trauma products; spine bone healing craniomaxillofacial and thoracic products; dental implants and related surgical products. The Company manages its operations through three geographic segments: the Americas comprising principally of the United States and includes other North Central and South American markets; Europe comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers and directly to dental practices and dental laboratories.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *